BACKGROUND: Adherence to inhaled anti-inflammatory therapy and self-management skills are essential parts of the asthma treatment plan to improve asthma control and prevent exacerbations. Whether self-management education improves long-term medication adherence is less clear. OBJECTIVE: A 24-week prospective, randomized controlled trial was performed to study the effect of self-management education on long-term adherence to inhaled corticosteroid (ICS) therapy and markers of asthma control. METHODS: After stabilization on ICS medication during a run-in phase, 95 adults with moderate-to-severe asthma were recruited from a large metropolitan community, and 84 were randomized toindividualized self-management education, including self-monitoring of symptoms and peak flow or usual care with self-monitoring alone. The key components of the 30-minute intervention were asthma information, assessment, and correction of inhaler technique; an individualized action plan based on self-monitoring data; and environmental control strategies for relevant allergen and irritant exposures. The intervention was personalized based on pulmonary function, allergen skin test reactivity, and inhaler technique and reinforced at 2-week intervals. RESULTS: Participants randomized to the self-management intervention maintained consistently higher ICS adherence levels and showed a 9-fold greater odds of more than 60% adherence to the prescribed dose compared with control subjects at the end of the intervention (P = .02) and maintained a 3-fold greater odds of higher than 60% adherence at the end of the study. Perceived control of asthma improved (P = .006), nighttime awakenings decreased (P = .03), and inhaled beta-agonist use decreased (P = .01) in intervention participants compared with control subjects. CONCLUSION: Our results show that individualized asthma self-management education attenuates the usual decrease in medication adherence and improves clinical markers of asthma control.
RCT Entities:
BACKGROUND: Adherence to inhaled anti-inflammatory therapy and self-management skills are essential parts of the asthma treatment plan to improve asthma control and prevent exacerbations. Whether self-management education improves long-term medication adherence is less clear. OBJECTIVE: A 24-week prospective, randomized controlled trial was performed to study the effect of self-management education on long-term adherence to inhaled corticosteroid (ICS) therapy and markers of asthma control. METHODS: After stabilization on ICS medication during a run-in phase, 95 adults with moderate-to-severe asthma were recruited from a large metropolitan community, and 84 were randomized to individualized self-management education, including self-monitoring of symptoms and peak flow or usual care with self-monitoring alone. The key components of the 30-minute intervention were asthma information, assessment, and correction of inhaler technique; an individualized action plan based on self-monitoring data; and environmental control strategies for relevant allergen and irritant exposures. The intervention was personalized based on pulmonary function, allergen skin test reactivity, and inhaler technique and reinforced at 2-week intervals. RESULTS:Participants randomized to the self-management intervention maintained consistently higher ICS adherence levels and showed a 9-fold greater odds of more than 60% adherence to the prescribed dose compared with control subjects at the end of the intervention (P = .02) and maintained a 3-fold greater odds of higher than 60% adherence at the end of the study. Perceived control of asthma improved (P = .006), nighttime awakenings decreased (P = .03), and inhaled beta-agonist use decreased (P = .01) in intervention participants compared with control subjects. CONCLUSION: Our results show that individualized asthma self-management education attenuates the usual decrease in medication adherence and improves clinical markers of asthma control.
Authors: Michael K Paasche-Orlow; Kristin A Riekert; Andrew Bilderback; Arjun Chanmugam; Peter Hill; Cynthia S Rand; Fred L Brancati; Jerry A Krishnan Journal: Am J Respir Crit Care Med Date: 2005-08-04 Impact factor: 21.405
Authors: J Coté; A Cartier; P Robichaud; H Boutin; J L Malo; M Rouleau; A Fillion; M Lavallée; M Krusky; L P Boulet Journal: Am J Respir Crit Care Med Date: 1997-05 Impact factor: 21.405
Authors: M S Simmons; M A Nides; E C Kleerup; K R Chapman; H Milgrom; C S Rand; S L Spector; D P Tashkin Journal: J Allergy Clin Immunol Date: 1998-09 Impact factor: 10.793
Authors: Rachelle R Ramsey; Julia K Caromody; Sara E Voorhees; Amanda Warning; Christopher C Cushing; Theresa W Guilbert; Kevin A Hommel; David A Fedele Journal: J Allergy Clin Immunol Pract Date: 2019-04-04
Authors: Katherine Mackey; Michael L Parchman; Luci K Leykum; Holly J Lanham; Polly H Noël; John E Zeber Journal: Prim Care Diabetes Date: 2012-01-20 Impact factor: 2.459
Authors: Justin Gatwood; Rajesh Balkrishnan; Steven R Erickson; Lawrence C An; John D Piette; Karen B Farris Journal: Res Social Adm Pharm Date: 2014-02-05
Authors: Jennifer L Kuntz; Monika M Safford; Jasvinder A Singh; Shobha Phansalkar; Sarah P Slight; Qoua Liang Her; Nancy Allen Lapointe; Robin Mathews; Emily O'Brien; William B Brinkman; Kevin Hommel; Kevin C Farmer; Elissa Klinger; Nivethietha Maniam; Heather J Sobko; Stacy C Bailey; Insook Cho; Maureen H Rumptz; Meredith L Vandermeer; Mark C Hornbrook Journal: Patient Educ Couns Date: 2014-09-16